Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(3.83)
# 1,863
Out of 4,421 analysts
1226
Total ratings
52%
Success rate
3.5%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SAN Sanofi | Maintained: Buy | €100.00 → €95.00 | $73.34 | +29.53% | 143 | Jun 15, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Sell | 11,500p | $13,154.00 | -12.57% | 185 | Jun 9, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 290.00 | $281.20 | +3.13% | 156 | Jun 9, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Buy | CHF 135.00 | $118.04 | +14.37% | 131 | Jun 9, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 1,900p | $1,923.00 | -1.20% | 165 | Jun 8, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Hold | $43 → $47 | $44.75 | +4.16% | 7 | Jun 4, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | $319.00 | +6.58% | 140 | May 27, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €725.00 → €750.00 | $764.20 | -1.86% | 32 | May 15, 2026 | |
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,400 → kr 2,250 | $1,614.50 | +39.36% | 23 | May 11, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $140 | $90.89 | +54.03% | 32 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 63.00 → CHF 70.00 | $67.68 | +3.43% | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $43.19 | - | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €285.00 → €295.00 | $249.31 | +18.33% | 25 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $877.72 | - | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €11.00 → €12.00 | $9.01 | +33.21% | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 → €14.00 | $11.14 | +25.67% | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | kr 285.00 | $440.20 | -35.26% | 17 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 | $24.58 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $42.38 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 1.00 | $5.85 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $63.96 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1,098.57 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $3.92 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.40 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €95.00 → €124.00 | $154.50 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $49.74 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.27 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €44.00 | $50.55 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $127 → $58 | $28.32 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $50.67 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.42 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €80.00 | $37.15 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €62.49 → €78.00 | $133.05 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $147.08 | n/a | 4 | Dec 7, 2018 |
Sanofi
Jun 15, 2026
Maintained: Buy
Price Target: €100.00 → €95.00
Current: $73.34
Upside: +29.53%
AstraZeneca PLC
Jun 9, 2026
Maintained: Sell
Price Target: 11,500p
Current: $13,154.00
Upside: -12.57%
Novo Nordisk A/S
Jun 9, 2026
Maintained: Hold
Price Target: kr 290.00
Current: $281.20
Upside: +3.13%
Novartis AG
Jun 9, 2026
Maintained: Buy
Price Target: CHF 135.00
Current: $118.04
Upside: +14.37%
GSK plc
Jun 8, 2026
Maintained: Hold
Price Target: 1,900p
Current: $1,923.00
Upside: -1.20%
Zealand Pharma A/S
Jun 4, 2026
Maintained: Hold
Price Target: $43 → $47
Current: $44.75
Upside: +4.16%
Roche Holding AG
May 27, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: $319.00
Upside: +6.58%
argenx SE
May 15, 2026
Maintained: Buy
Price Target: €725.00 → €750.00
Current: $764.20
Upside: -1.86%
Genmab A/S
May 11, 2026
Maintained: Buy
Price Target: kr 2,400 → kr 2,250
Current: $1,614.50
Upside: +39.36%
BioNTech SE
Mar 17, 2026
Maintained: Buy
Price Target: $140
Current: $90.89
Upside: +54.03%
Feb 26, 2026
Downgraded: Hold
Price Target: CHF 63.00 → CHF 70.00
Current: $67.68
Upside: +3.43%
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.19
Upside: -
Dec 8, 2025
Maintained: Buy
Price Target: €285.00 → €295.00
Current: $249.31
Upside: +18.33%
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $877.72
Upside: -
Aug 5, 2025
Maintained: Hold
Price Target: €11.00 → €12.00
Current: $9.01
Upside: +33.21%
Jul 28, 2025
Maintained: Buy
Price Target: €12.00 → €14.00
Current: $11.14
Upside: +25.67%
Jul 8, 2025
Upgraded: Hold
Price Target: kr 285.00
Current: $440.20
Upside: -35.26%
Apr 28, 2025
Maintained: Hold
Price Target: €22.00
Current: $24.58
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $42.38
Upside: n/a
Nov 29, 2024
Maintained: Hold
Price Target: CHF 1.00
Current: $5.85
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $63.96
Upside: n/a
Jul 17, 2024
Maintained: Hold
Price Target: n/a
Current: $1,098.57
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $3.92
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $7.40
Upside: n/a
Aug 7, 2023
Maintained: Hold
Price Target: €95.00 → €124.00
Current: $154.50
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $49.74
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $25.27
Upside: n/a
Aug 9, 2022
Maintained: Hold
Price Target: €44.00
Current: $50.55
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $127 → $58
Current: $28.32
Upside: n/a
Apr 16, 2021
Maintained: Sell
Price Target: n/a
Current: $50.67
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $16.42
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: €80.00
Current: $37.15
Upside: n/a
Jan 15, 2019
Maintained: Sell
Price Target: €62.49 → €78.00
Current: $133.05
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $147.08
Upside: n/a